Prevalence of chronic kidney disease in Tunisian diabetics: the TUN-CKDD survey.
Albuminuria
Chronic kidney failure
Diabetes mellitus
Prevalence
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
25 Feb 2024
25 Feb 2024
Historique:
received:
24
06
2023
accepted:
14
02
2024
medline:
26
2
2024
pubmed:
26
2
2024
entrez:
25
2
2024
Statut:
epublish
Résumé
In Tunisia, the prevalence of diabetes mellitus increased from 15.5% on 2016 to 23% by 2023. While Chronic Kidney Disease (CKD) stills the most dreaded complications of diabetes, studies on the prevalence of chronic kidney disease non-dialysis diet are scarce. The aim of this study was to assess the prevalence of chronic kidney disease among the Tunisian diabetic population based on investigators' specialty, demographic criteria (gender, age, duration of diabetes and geographic distribution) and diagnosis criteria (albuminuria and/or eGFR). This observational, multicentric, and cross-sectional study enrolled all diabetic subjects from all regions of Tunisia with at least 3 months of follow-up before the inclusion date, from 09 January to 08 February 2023. CKD diagnosis was established based on the KDIGO guidelines. The study was carried out at medical departments and ambulatory clinics of different healthcare providers. Baseline data were collected by investigators using an electronic case report form (eCRF). Continuous variables were described by means, median, standard deviation, and quartiles. Categorical data were tabulated in frequencies and percentages. The overall prevalence of CKD among the 10,145 enrolled patients with diabetes mellitus was 38.7% with a 95%CI [37.8-39.6%]. 50.9% were male, with a mean age of 67.5 (± 11.3) years. The mean diabetes duration was 16.1 years (± 8.9). The highest CKD prevalence was noted among nephrologists (82.2%), while it was similar between the cardiologists and the primary care physicians (30.0%). CKD prevalence was highest among males (43.0% versus 35.1%) and increased proportionally with patients' age and diabetes duration. CKD was more frequent in the Mid-East Area when compared to other regions (49.9% versus 25.3 to 40.1% in other regions). Albuminuria was present within 6.6% of subjects with CKD, and it was found an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m² within 13.3% of subjects wit h CKD. 18.9% had both criteria. In Tunisia, CKD among diabetics had a prevalence of 38.7%, approaching European prevalence. The prevalence discrepancy worldwide of CKD can be improved with a larger population size and by implementing standardized practices.
Sections du résumé
BACKGROUND
BACKGROUND
In Tunisia, the prevalence of diabetes mellitus increased from 15.5% on 2016 to 23% by 2023. While Chronic Kidney Disease (CKD) stills the most dreaded complications of diabetes, studies on the prevalence of chronic kidney disease non-dialysis diet are scarce. The aim of this study was to assess the prevalence of chronic kidney disease among the Tunisian diabetic population based on investigators' specialty, demographic criteria (gender, age, duration of diabetes and geographic distribution) and diagnosis criteria (albuminuria and/or eGFR).
METHODS
METHODS
This observational, multicentric, and cross-sectional study enrolled all diabetic subjects from all regions of Tunisia with at least 3 months of follow-up before the inclusion date, from 09 January to 08 February 2023. CKD diagnosis was established based on the KDIGO guidelines. The study was carried out at medical departments and ambulatory clinics of different healthcare providers. Baseline data were collected by investigators using an electronic case report form (eCRF). Continuous variables were described by means, median, standard deviation, and quartiles. Categorical data were tabulated in frequencies and percentages.
RESULTS
RESULTS
The overall prevalence of CKD among the 10,145 enrolled patients with diabetes mellitus was 38.7% with a 95%CI [37.8-39.6%]. 50.9% were male, with a mean age of 67.5 (± 11.3) years. The mean diabetes duration was 16.1 years (± 8.9). The highest CKD prevalence was noted among nephrologists (82.2%), while it was similar between the cardiologists and the primary care physicians (30.0%). CKD prevalence was highest among males (43.0% versus 35.1%) and increased proportionally with patients' age and diabetes duration. CKD was more frequent in the Mid-East Area when compared to other regions (49.9% versus 25.3 to 40.1% in other regions). Albuminuria was present within 6.6% of subjects with CKD, and it was found an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m² within 13.3% of subjects wit h CKD. 18.9% had both criteria.
CONCLUSIONS
CONCLUSIONS
In Tunisia, CKD among diabetics had a prevalence of 38.7%, approaching European prevalence. The prevalence discrepancy worldwide of CKD can be improved with a larger population size and by implementing standardized practices.
Identifiants
pubmed: 38403649
doi: 10.1186/s12882-024-03501-5
pii: 10.1186/s12882-024-03501-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
67Informations de copyright
© 2024. The Author(s).
Références
International Diabetes Federation. IDF Atlas, 10th edition. Available from: https://www.diabetesatlas.org
Ministry of Health, National Institute for Health. Tunisian Health Examination Survey-2016. 2016.
Jemaa R, Razgallah R, Rais L, Ben Ghorbel I, Feki M, Kallel A. Prevalence of diabetes in the Tunisian population: results of the ATERA-survey. Archives Cardiovasc Dis Supplements. 2023;15(1):131.
doi: 10.1016/j.acvdsp.2022.10.253
Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KAM, Zoungas S, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1(1):15018.
doi: 10.1038/nrdp.2015.18
pubmed: 27188921
pmcid: 7724636
Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69(11):2057–63.
doi: 10.1038/sj.ki.5000377
pubmed: 16612330
Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. 2005;68:7–10.
Reutens AT, Atkins RC. Epidemiology of diabetic nephropathy. In: Lai KN, Tang SCW, Contributions to Nephrology. Karger S. AG; 2011 [cited 2023 May 16]. p. 1–7. Available from: https://www.karger.com/Article/FullText/324934
Abd ElHafeez S, Bolignano D, D’Arrigo G, Dounousi E, Tripepi G, Zoccali C. Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review. BMJ Open. 2018;8(1):e015069.
doi: 10.1136/bmjopen-2016-015069
pubmed: 29326180
pmcid: 5780690
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement1):15–33.
doi: 10.2337/dc21-S002
Kidney Disease. Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18(10):2749–57.
doi: 10.1681/ASN.2007020199
pubmed: 17855641
Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y (Lucy), Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–54.
Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al. The epidemiology of chronic kidney disease in sub-saharan Africa: a systematic review and meta-analysis. Lancet Global Health. 2014;2(3):e174–81.
doi: 10.1016/S2214-109X(14)70002-6
pubmed: 25102850
Al-Rubeaan K, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, Al-Mutlaq HM et al. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi national diabetes registry-based study. Alvarez ML, editor. PLoS ONE. 2014;9(2):e88956.
Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, et al. Diabetes and CKD in the United States population, 2009–2014. CJASN. 2017;12(12):1984–90.
doi: 10.2215/CJN.03700417
pubmed: 29054846
pmcid: 5718269
Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S, Diabetes. 2030: insights from yesterday, today, and future trends. Population Health Management. 2017;20(1):6–12.
Chu L, Fuller M, Jervis K, Ciaccia A, Abitbol A. Prevalence of chronic kidney disease in type 2 diabetes: the Canadian REgistry of chronic kidney disease in diabetes outcomes (CREDO) study. Clin Ther. 2021;43(9):1558–73.
doi: 10.1016/j.clinthera.2021.07.015
pubmed: 34426012
Hagnäs M, Sundqvist H, Jokelainen J, Tumminia A, Vinciguerra F, Loreto C, et al. The prevalence of chronic kidney disease and screening of renal function in type 2 diabetic patients in Finnish primary healthcare. Prim Care Diabetes. 2020;14(6):639–44.
doi: 10.1016/j.pcd.2020.05.005
pubmed: 32527663
Migdalis IN, Papanas N, Raptis AE, Ioannidis IM, Sotiropoulos AE, Dimitriadis GD. The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: a series from hospital-based diabetes clinics. Diabetes Res Clin Pract. 2020;166:108243.
doi: 10.1016/j.diabres.2020.108243
pubmed: 32502694
Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1):e007525.
doi: 10.1136/bmjgh-2021-007525
pubmed: 35078812
pmcid: 8796212
An L, Yu Q, Tang H, Li X, Wang D, Tang Q, et al. The prevalence, progress and risk factor control of chronic kidney disease in Chinese adults with type 2 diabetes mellitus in primary care. Front Endocrinol. 2022;13:859266.
doi: 10.3389/fendo.2022.859266
Khunti K, Charbonnel B, Chen H, Cherney DZ, Cooper A, Fenici P, et al. Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: insights from the DISCOVER study. Diabetes Obes Metab. 2021;23(8):1956–60.
doi: 10.1111/dom.14401
pubmed: 33852196
Joshi R, Subedi P, Yadav GK, Khadka S, Rijal T, Amgain K, et al. Prevalence and risk factors of chronic kidney disease among patients with type 2 diabetes mellitus at a tertiary care hospital in Nepal: a cross-sectional study. BMJ Open. 2023;13(2):e067238.
doi: 10.1136/bmjopen-2022-067238
pubmed: 36854582
pmcid: 9980322
Schwandt A, Denkinger M, Fasching P, Pfeifer M, Wagner C, Weiland J, et al. Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with diabetes. J Diabetes Complicat. 2017;31(9):1376–83.
doi: 10.1016/j.jdiacomp.2017.06.016
Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–9.
doi: 10.2215/CJN.06870909
pubmed: 20299365
pmcid: 2879308
KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2):12–54.
doi: 10.1053/j.ajkd.2006.12.005
Levey AS, Stevens LA, Schmid CH, Zhang Y (Lucy), Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604.
Helou R. Should we continue to use the Cockcroft-Gault Formula? Nephron Clin Pract. 2010;116(3):c172–86.
doi: 10.1159/000317197
pubmed: 20606477
Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151–64.
doi: 10.1038/nrneph.2017.181
pubmed: 29355169
Piani F, Melena I, Tommerdahl KL, Nokoff N, Nelson RG, Pavkov ME, et al. Sex-related differences in diabetic kidney disease: a review on the mechanisms and potential therapeutic implications. J Diabetes Complicat. 2021;35(4):107841.
doi: 10.1016/j.jdiacomp.2020.107841
Giandalia A, Giuffrida AE, Gembillo G, Cucinotta D, Squadrito G, Santoro D, et al. Gender differences in diabetic kidney disease: focus on hormonal, genetic and clinical factors. IJMS. 2021;22(11):5808.
doi: 10.3390/ijms22115808
pubmed: 34071671
pmcid: 8198374
Filler G, Ramsaroop A, Stein R, Grant C, Marants R, So A, et al. Is testosterone detrimental ren function? Kidney Int Rep. 2016;1(4):306–10.
Jin H, Kim YA, Lee Y, Kwon S, hyun, Do AR, Seo S, et al. Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis. BMC Med. 2023;21(1):16.
doi: 10.1186/s12916-022-02723-4
pubmed: 36627639
pmcid: 9832630
Rizvi S. Association of genetic variants with diabetic nephropathy. WJD. 2014;5(6):809.
doi: 10.4239/wjd.v5.i6.809
pubmed: 25512783
pmcid: 4265867
Kato M, Natarajan R. Diabetic nephropathy—emerging epigenetic mechanisms. Nat Rev Nephrol. 2014;10(9):517–30.
doi: 10.1038/nrneph.2014.116
pubmed: 25003613
pmcid: 6089507
Vujkovic M, Keaton JM, Lynch JA, Miller DR, Zhou J, Tcheandjieu C, et al. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020;52(7):680–91.
doi: 10.1038/s41588-020-0637-y
pubmed: 32541925
pmcid: 7343592
Unnikrishnan R, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, et al. Prevalence and risk factors of diabetic nephropathy in an Urban South Indian population. Diabetes Care. 2007;30(8):2019–24.
doi: 10.2337/dc06-2554
pubmed: 17488949
Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res. 2012;136(1):46–53.
pubmed: 22885263
pmcid: 3461717
Wu B, Bell K, Stanford A, Kern DM, Tunceli O, Vupputuri S, et al. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012. BMJ Open Diab Res Care. 2016;4(1):e000154.
doi: 10.1136/bmjdrc-2015-000154
pubmed: 27110365
pmcid: 4838667
Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, for the UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes. Diabetes. 2006;55(6):1832–9.
doi: 10.2337/db05-1620
pubmed: 16731850
Bouzid C, Smida H, Kacem A. L’insuffisance rénale Chez Des diabétiques de type 2 Tunisiens hospitalisés: fréquence et facteurs associés. 2011;89(01):10–5.
Cherni L, Pakstis AJ, Boussetta S, Elkamel S, Frigi S, Khodjet-El‐Khil H, et al. Genetic variation in Tunisia in the context of human diversity worldwide. Am J Phys Anthropol. 2016;161(1):62–71.
doi: 10.1002/ajpa.23008
pubmed: 27192181
pmcid: 5084816
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659.
doi: 10.1001/archinte.164.6.659
pubmed: 15037495
Peralta CA, Shlipak MG, Fan D, Ordon[Combining Tilde]ez J, Lash JP, Chertow GM, et al. Risks for end-stage renal disease, cardiovascular events, and death in hispanic versus non-hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2892–9.
Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–95.
doi: 10.1681/ASN.2004030203
pubmed: 15590763
Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26(4):379–85.
doi: 10.1007/s11606-010-1511-x
pubmed: 20853156